Last update 22 Mar 2025

ZN-c5

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
ZN C5
Target
Action
degraders
Mechanism
ERs degraders(Estrogen receptors degraders)
Originator Organization
Inactive Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Breast CancerPhase 2
China
30 Jan 2022
Human epidermal growth factor 2 negative carcinoma of breastPhase 2
United States
30 Nov 2018
Human epidermal growth factor 2 negative carcinoma of breastPhase 2
Belarus
30 Nov 2018
Human epidermal growth factor 2 negative carcinoma of breastPhase 2
Bosnia and Herzegovina
30 Nov 2018
Human epidermal growth factor 2 negative carcinoma of breastPhase 2
Czechia
30 Nov 2018
Human epidermal growth factor 2 negative carcinoma of breastPhase 2
Hungary
30 Nov 2018
Human epidermal growth factor 2 negative carcinoma of breastPhase 2
Lithuania
30 Nov 2018
Human epidermal growth factor 2 negative carcinoma of breastPhase 2
Russia
30 Nov 2018
Human epidermal growth factor 2 negative carcinoma of breastPhase 2
Serbia
30 Nov 2018
Human epidermal growth factor 2 negative carcinoma of breastPhase 2
Ukraine
30 Nov 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1/2
56
mxrqsgqlke(cxzkukabvc) = hzbiaavljf qgznoaulne (uldpycvruh )
Positive
15 Feb 2022
Phase 1
ER-positive/HER2-negative Breast Cancer
Third line
ER positive | HER2 negative
72
(Across all doses from 50 mg QD to 300 mg QD)
sddpsoqiti(nnlqyoaghq) = hrjagkefmo dzktgzydvr (tqmjqhnqsr )
Positive
28 Jun 2021
(An oral dose of 50 mg QD)
iqtqhjledm(efmmrudezx) = dtvycofeni eygvvnxlbr (mceczoojqe )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free